Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals [NA]
A clinical trial (ImmunoCARE) evaluated rapid, accurate COVID-19 testing to reduce hospitalizations among immunocompromised individuals. The…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial update for relapsed and relapsed/refractory multiple myeloma patients, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial update describing a steroid-sparing treatment approach for newly diagnosed transplant-ineligible patients with mult…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: GMMG Multiple Myeloma Registry
The document is an update on the GMMG Multiple Myeloma Registry, a recruiting observational study intended to collect data on patients with …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]
This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple my…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM [Phase 1, Phase 2]
A Phase 1/2 clinical trial in China evaluating autologous stem cell transplantation combined with BCMA CAR-T therapy for ultra high risk mul…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating the combination of leflunomide, pomalidomide, and dexamethasone for relapsed or refractory multiple myel…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating Modakafusp Alfa in combination with Daratumumab for adults with relapsed or refractory multiple myeloma has been …
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma [Phase 1]
Phase 1 study evaluating Modakafusp alfa in adults with multiple myeloma has been terminated, and trial results have been posted.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma [Phase 2]
A Phase 2 clinical trial is exploring autologous stem cell transplant followed by maintenance with BCMA CAR-T cells and GPRC5D/CD3 BiTEs for…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating MRD-adaptive guided CAR-T immunotherapy in transplant-ineligible patients with multiple myeloma; the study is curre…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma [Phase 2]
This is an update on a Phase II clinical trial evaluating siltuximab for preventing or treating CRS/ICANs after CAR-T therapy in patients wi…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia [Phase 2]
A Phase 2 clinical trial evaluating autologous stem cell transplant (ASCT) followed by maintenance with BCMA CAR-T cells and GPRC5D/CD3 BiTE…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Phase I Trial of GR1803 Injection in Patients With RRMM [Phase 1, Phase 2]
Phase I/II clinical trial update for GR1803 injection in relapsed/refractory multiple myeloma; the study has completed.
-
FDA approval · 2025-08-05FDA Approved: POMALIDOMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application from Aurobindo Pharma Limited for pomalidomide, permitting the marketing of a generic pomalidomide p…
-
FDA approval · 2025-08-05FDA Approved: POMALIDOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva's supplemental application for pomalidomide (ANDA 209956), yielding a generic pomalidomide product.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial (TG01/QS-21 vaccine) is evaluating a peptide vaccine with QS-21 adjuvant in high-risk smoldering multiple myeloma…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT [NA]
A completed clinical trial update from Case Comprehensive Cancer Center about a transplant wellness clinic for elderly or high-risk patients…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) [Phase 2]
A Phase 2 study evaluating venetoclax in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma; the tria…
-
FDA approval · 2025-08-05FDA Approved: POMALIDOMIDE — Supplemental Application (Natco Pharma Limited)
FDA approved a supplemental application for pomalidomide from Natco Pharma Limited, granting approval for this generic product.
-
CLINICAL_TRIALS research · 2025-08-04Clinical Trial Update: A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities [Phase 2]
A Phase 2 clinical study evaluating a VRd-based regimen combined with CART-ASCT-CART2 in newly diagnosed multiple myeloma patients with p53 …
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of DKN-01 in combination with lenalidomide and dexamethasone for relapsed or re…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: BCMA CAR-T for Dynamic High-risk Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating a BCMA-targeted CAR-T therapy for dynamic high-risk multiple myeloma, with recruitment ongoing in China.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma [Phase 2]
Clinical trial update for a Phase 2 study evaluating a VRd-based regimen followed by BCMA CAR-T therapy in transplant-ineligible patients wi…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial in China is comparing BCMA CAR-T therapy to autologous stem cell transplant in transplant-eligible patients with multiple my…